The R/S is still on the table so I, need to know where that is going. Results of trials have to be published. I, for one will not own more than a token amount of shares until I hear news on both. I'll, gladly buy at a higher price as long as the risk/reward improves.
Black, it's past just hoping for things to work out, because now ACTC is in the stretch run where it's pass or fail, but at least we'll know the answer within the next year. And I'm still betting it'll pass with flying colors, and I mean really bright flying colors.
keep: Unless we have been flat out lied to, the great results are there, just waiting to be released.
As I have seen with GERN's Imetelstat results on MF, a large part of the problem is getting the results published in enough places where they are generally known and available to the public. For obvious reasons, this is not always something easy to do. Competitors just don't like to be put out of business.
So, I'm hoping that one of the first things on Wotton's list is to start getting the results publicized. Period. Forget the NEJM if it's going to take months longer.
ACTC investors have suffered for too long. It's time to begin the prosperous journey forward.